114 related articles for article (PubMed ID: 38800386)
1. Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.
Ricci C; Subburaj D; Lim K; Shukla N; Kaur J; Xie L; Laverty M; Zakaria D; Pole J; Pelland-Marcotte MC; Barber R; Israels SJ; Tran TH; Oberoi S; Renzi S; MacDonald T; Sung L; Kulkarni K
Front Oncol; 2024; 14():1418512. PubMed ID: 38800386
[TBL] [Abstract][Full Text] [Related]
2. Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.
Ricci C; Subburaj D; Lim K; Shukla N; Kaur J; Xie L; Laverty M; Zakaria D; Pole J; Pelland-Marcotte MC; Barber R; Israels SJ; Tran TH; Oberoi S; Renzi S; MacDonald T; Sung L; Kulkarni K
Front Oncol; 2024; 14():1376652. PubMed ID: 38606094
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients.
Mosleh E; Snyder S; Wu N; Willis DN; Malone R; Hayashi RJ
Front Oncol; 2023; 13():1333273. PubMed ID: 38090499
[TBL] [Abstract][Full Text] [Related]
4. Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.
Pole JD; Darmawikarta D; Gassas A; Ali M; Egler M; Greenberg ML; Doyle J; Nathan PC; Schechter T
Bone Marrow Transplant; 2015 May; 50(5):721-6. PubMed ID: 25706885
[TBL] [Abstract][Full Text] [Related]
5. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database.
Jiao Z; Feng Z; Yan Z; Zhang J; Li G; Wang G; Wang Q; Feng D
Front Oncol; 2022; 12():859596. PubMed ID: 35223531
[TBL] [Abstract][Full Text] [Related]
9. Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study.
Kier MG; Hansen MK; Lauritsen J; Mortensen MS; Bandak M; Agerbaek M; Holm NV; Dalton SO; Andersen KK; Johansen C; Daugaard G
JAMA Oncol; 2016 Dec; 2(12):1624-1627. PubMed ID: 27711914
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Photodynamic therapy for malignant brain tumors in children and young adolescents.
Chiba K; Aihara Y; Oda Y; Fukui A; Tsuzuki S; Saito T; Nitta M; Muragaki Y; Kawamata T
Front Oncol; 2023; 13():1158407. PubMed ID: 37182164
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: A SEER population-based analysis.
Lin Q; Bao JH; Xue F; Qin JJ; Chen Z; Chen ZR; Li C; Yan YX; Fu J; Shen ZL; Chen XZ
Front Oncol; 2022; 12():995352. PubMed ID: 35992859
[TBL] [Abstract][Full Text] [Related]
12. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries.
Garwicz S; Anderson H; Olsen JH; Døllner H; Hertz H; Jonmundsson G; Langmark F; Lanning M; Möller T; Sankila R; Tulinius H
Int J Cancer; 2000 Nov; 88(4):672-8. PubMed ID: 11058888
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Melanoma in Adolescents and Young Adults (AYA): Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study.
Del Fiore P; Russo I; Ferrazzi B; Monico AD; Cavallin F; Filoni A; Tropea S; Russano F; Di Prata C; Buja A; Collodetto A; Spina R; Carraro S; Cappellesso R; Nicolè L; Chiarion-Sileni V; Pigozzo J; Dall'Olmo L; Rastrelli M; Vecchiato A; Benna C; Menin C; Di Carlo D; Bisogno G; Dei Tos AP; Alaibac M; Mocellin S
Front Oncol; 2021; 11():793169. PubMed ID: 34778096
[TBL] [Abstract][Full Text] [Related]
15. Increased Risk of Suicide among Cancer Survivors Who Developed a Second Malignant Neoplasm.
Yang H; Qu Y; Shang Y; Wang C; Wang J; Lu D; Song H
Comput Intell Neurosci; 2022; 2022():2066133. PubMed ID: 35047029
[TBL] [Abstract][Full Text] [Related]
16. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.
Yin X; Chen L; Fan F; Yan H; Zhang Y; Huang Z; Sun C; Hu Y
Front Oncol; 2021; 11():657016. PubMed ID: 33680976
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Commentary: AI-based online chat and the future of oncology care: a promising technology or a solution in search of a problem?
Zhang H; Guan Y; Chen J; Tong W
Front Oncol; 2023; 13():1334176. PubMed ID: 38144532
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: An ultrasonic-based radiomics nomogram for distinguishing between benign and malignant solid renal masses.
Li C; Qiao G; Li J; Qi L; Wei X; Zhang T; Li X; Deng S; Wei X; Ma W
Front Oncol; 2023; 13():1232714. PubMed ID: 37388225
[TBL] [Abstract][Full Text] [Related]
20. Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors.
Lim H; Im M; Seo ES; Cho HW; Ju HY; Yoo KH; Cho SY; Kim JW; Lim DH; Sung KW; Lee JW
Cancer Res Treat; 2024 Apr; 56(2):642-651. PubMed ID: 37997325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
